檢索結果 - Paul Frankel
- Showing 1 - 20 results of 52
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
A phase 2 study of belinostat (PXD101) in patients with relapsed or refractory acute myeloid leukemia or patients over the age of 60 with newly diagnosed acute myeloid leukemia: a... 由 Mark Kirschbaum, Kenneth A. Foon, Paul Frankel, Christopher Ruel, Bernadette Pulone, Joseph M. Tuscano, Edward M. Newman
出版 2013Artigo -
7
Chondroitin sulphate‐modified neuropilin 1 is expressed in human tumour cells and modulates 3D invasion in the U87MG human glioblastoma cell line through a p130Cas‐mediated pathway... 由 Paul Frankel, Caroline Pellet‐Many, Pauliina Lehtolainen, Giovanna M. D’Abaco, Michelle Tickner, Lili Cheng, Ian Zachary
出版 2008Artigo -
8
-
9
Multiple biomarker expression on circulating tumor cells in comparison to tumor tissues from primary and metastatic sites in patients with locally advanced/inflammatory, and stage... 由 George Somlo, Sean K. Lau, Paul Frankel, Huangpin B. Hsieh, Xiaohe Liu, Lixin Yang, Robert T. Krivacic, Richard H. Bruce
出版 2011Artigo -
10
Phase II Study of Belinostat (PXD101), a Histone Deacetylase Inhibitor, for Second Line Therapy of Advanced Malignant Pleural Mesothelioma 由 Suresh S. Ramalingam, Chandra P. Belani, Christopher Ruel, Paul Frankel, Barbara J. Gitlitz, Marianna Koczywas, Igor Espinoza‐Delgado, David R. Gandara
出版 2009Artigo -
11
-
12
Imatinib and Nilotinib increase glioblastoma cell invasion via Abl-independent stimulation of p130Cas and FAK signalling 由 Antonina Frolov, Ian Evans, Ningning Li, Kastytis Šidlauskas, Ketevan Paliashvili, Nicola Lockwood, Angela N. Barrett, Sebastian Brandner, Ian Zachary, Paul Frankel
出版 2016Artigo -
13
-
14
-
15
Phase II Study of Aflibercept (VEGF-Trap) in Patients With Recurrent or Metastatic Urothelial Cancer, a California Cancer Consortium Trial 由 Przemyslaw Twardowski, Walter M. Stadler, Paul Frankel, Primo N. Lara, Christopher Ruel, Gurkamal Chatta, Elisabeth I. Heath, David I. Quinn, David R. Gandara
出版 2010Artigo -
16
-
17
Endosome-to-Plasma Membrane Recycling of VEGFR2 Receptor Tyrosine Kinase Regulates Endothelial Function and Blood Vessel Formation 由 Helen M. Jopling, Adam F. Odell, Caroline Pellet‐Many, Antony M. Latham, Paul Frankel, Asipu Sivaprasadarao, John H. Walker, Ian Zachary, Sreenivasan Ponnambalam
出版 2014Artigo -
18
-
19
A phase I trial of mushroom powder in patients with biochemically recurrent prostate cancer: Roles of cytokines and myeloid‐derived suppressor cells for <i>Agaricus bisporus</i>–in... 由 Przemyslaw Twardowski, Noriko Kanaya, Paul Frankel, Timothy W. Synold, Christopher Ruel, Sumanta K. Pal, Maribel Junqueira, Manisha Prajapati, Tina Moore, P. Tryon, Shiuan Chen
出版 2015Artigo -
20
Functional Imaging of Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer Using <sup>64</sup>Cu-DOTA-Trastuzumab PET 由 Joanne Mortimer, James R. Bading, David Colcher, Peter S. Conti, Paul Frankel, Mary Carroll, Shan Tong, Erasmus Poku, Joshua K. Miles, John E. Shively, Andrew Raubitschek
出版 2013Artigo
相關主題
Medicine
Internal medicine
Cancer
Oncology
Biology
Biochemistry
Cancer research
Gene
Chemotherapy
Gastroenterology
Breast cancer
Cell biology
Adverse effect
Clinical trial
Chemistry
Pathology
Signal transduction
Surgery
VEGF receptors
Clinical endpoint
Immunology
Vascular endothelial growth factor
Genetics
Phases of clinical research
Receptor
Tolerability
Immunotherapy
Metastatic breast cancer
Pharmacology
Cisplatin